anmelden
Candriam Equities L Biotechnology Class I Fonds
2.307,69
CHF
+55,23
CHF
+2,45
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Vertex Pharmaceuticals Inc | US92532F1003 | 4,56% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 4,29% |
| Gilead Sciences Inc | US3755581036 | 3,97% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 3,90% |
| Amgen Inc | US0311621009 | 3,77% |
| Insmed Inc | US4576693075 | 3,37% |
| Biogen Inc | US09062X1037 | 2,85% |
| United Therapeutics Corp | US91307C1027 | 2,73% |
| Roivant Sciences Ltd Ordinary Shares | BMG762791017 | 2,56% |
| Ionis Pharmaceuticals Inc | US4622221004 | 2,43% |
| Sonstige | 65,57% |